Repare Therapeutics Announces Board and Executive Changes
| Field | Detail |
|---|---|
| Company | Repare Therapeutics Inc. |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, governance
TL;DR
Repare Therapeutics shuffled its board and exec pay. Big changes coming?
AI Summary
Repare Therapeutics Inc. announced on June 13, 2025, changes in its board of directors and executive compensation arrangements. Specifically, the company reported the departure of certain directors and officers, the election of new directors, and adjustments to compensatory arrangements for its key executives.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, potentially impacting investor confidence and stock performance.
Risk Assessment
Risk Level: medium — Board and executive changes can introduce uncertainty regarding future strategy and leadership stability.
Key Players & Entities
- Repare Therapeutics Inc. (company) — Registrant
- June 13, 2025 (date) — Date of earliest event reported
- 7171 Frederick-Banting, Building 2, Suite 270 (address) — Principal Executive Offices
- St-Laurent, Québec, Canada (location) — Principal Executive Offices Location
- H4S 1Z9 (zip_code) — Principal Executive Offices Zip Code
FAQ
Who are the departing directors or officers?
The filing states there was a departure of directors or certain officers but does not name the specific individuals.
Who are the newly elected directors?
The filing indicates the election of directors but does not provide their names.
What specific changes were made to compensatory arrangements?
The filing mentions compensatory arrangements of certain officers were adjusted but does not detail the nature of these changes.
What is the exact date of the earliest event reported?
The earliest event reported is dated June 13, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at 7171 Frederick-Banting, Building 2, Suite 270, St-Laurent, Québec, Canada, H4S 1Z9.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Repare Therapeutics Inc..